Graham Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
73,968
-152,327
| -67% | -$568K | ﹤0.01% | 985 |
|
|
2025
Q1 | $625K | Buy |
226,295
+93,296
| +70% | +$257K | 0.01% | 689 |
|
|
2024
Q4 | $737K | Buy |
132,999
+119,661
| +897% | +$663K | 0.01% | 561 |
|
|
2024
Q3 | $111K | Sell |
13,338
-18,771
| -58% | -$157K | ﹤0.01% | 963 |
|
|
2024
Q2 | $219K | Buy |
32,109
+1,878
| +6% | +$12.8K | ﹤0.01% | 813 |
|
|
2024
Q1 | $198K | Buy |
+30,231
| New | +$198K | ﹤0.01% | 877 |
|
|
2023
Q4 | – | Sell |
-82,978
| Closed | -$417K | – | 1309 |
|
|
2023
Q3 | $417K | Buy |
82,978
+53,998
| +186% | +$272K | 0.01% | 598 |
|
|
2023
Q2 | $254K | Buy |
+28,980
| New | +$254K | 0.01% | 733 |
|